My proposal now is to test a vaccine first on people who have been infected, and if you show some efficacy at this level, you might be able to go further to study uninfected people in a population with a high rate of infection.
We use cookies to understand our websites traffic and offer our website visitors personalized experience. To find out more, click ‘More Information’. In addition, please, read our
Privacy policy.